Loading clinical trials...
Loading clinical trials...
The purpose of this study is to compare the efficacy and safety of intravenous (IV) infusions of MT-3921 to placebo in subjects with acute traumatic cervical spinal cord injury. Subjects meeting elig...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Tanabe Pharma America, Inc.
NCT07213986 · Neurogenic Bowel Dysfunction, Spinal Cord Injury
NCT07511244 · Bladder and Bowel Dysfunction, SCI - Spinal Cord Injury
NCT04894734 · Spinal Cord Injury at T1-T12 Level, Traumatic Thoracic Spinal Cord Contusion, and more
NCT04755699 · Healthy Volunteers, Spinal Cord Injury, and more
NCT06587607 · Spinal Cord Injury, Chronic Pain
University of California Irvine
Orange, California
Tallahassee Neurological Clinic
Tallahassee, Florida
Augusta University
Augusta, Georgia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions